CORVENTIS
Live / Applied — New application — not yet assigned to an examiner (as of 25 Jun 2026)
What this means for you
Not registered yet, but its 25 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99904994
- Mark type
- Word mark
- Filed
- 25 Jun 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biotechnology, and clinical trials; pharmaceutical research and development; pharmaceutical products development; research and development in the field of biotechnology
Owner
- Atrium Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 25 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 25 Jun 2026 — NEW APPLICATION ENTERED